FEDER-CDTI Kinsy
FEDER-CDTI Kinsy funding plays a strategic role in driving our continuous commitment to chemical innovation, process efficiency, and sustainable pharmaceutical development. Kinsy keeps investing in R&D+i to improve production processes, products, and specialized CDMO services through state-of-the-art technological innovation.
New equipment, featuring state-of-the-art technology, is an essential part of our R&D Center and pilot plant facilities dedicated to the development and manufacturing of advanced Active Pharmaceutical Ingredients (APIs) and fine chemicals.
Good Practices in FEDER-CDTI Funded Projects
The financial support from European Regional Development Funds (FEDER) and the Centre for the Development of Technology and Innovation (CDTI) allows us to strengthen our industrial infrastructure. Implementing these public grants requires strict adherence to transparency, regulatory compliance, and high quality standards across all project phases.
Key highlights of our technological development strategy include:
- Process Optimization: Modernizing chemical synthesis pathways for scalable and safe API production.
- Infrastructure Upgrade: Incorporating advanced analytical and reaction equipment in our pilot plant.
- Environmental Sustainability: Reducing environmental impact through greener chemical manufacturing practices.
Driving Innovation in API Manufacturing
Through the successful execution of these subsidized R&D+i initiatives, Kinsy reinforces its market position as a reliable European CDMO partner for the global pharmaceutical sector. If you would like to know more about our industrial capabilities, feel free to explore our product catalog or contact our team.
For more details on funding programs and official regulatory guidelines, visit the official CDTI official portal.
